Prevalence and influencing factors of insomnia in patients with coronary heart disease: a systematic review and meta-analysis - Takeaways - MDSpire

Prevalence and influencing factors of insomnia in patients with coronary heart disease: a systematic review and meta-analysis

  • By

  • Shu-lan Liu

  • Ya Chen

  • Xiao-di Bai

  • Ting Xu

  • He-yao Xu

  • Si-yu Lin

  • Xin-yao Zhou

  • Yun-lan Jiang

  • April 1, 2026

  • 0 min

Share

  • 1

    Insomnia prevalence in coronary heart disease (CHD) patients is significant, with a pooled rate of 51.8% identified in the meta-analysis.

  • 2

    Key risk factors for insomnia in CHD patients include female sex, anxiety, depression, diabetes, and gastritis.

  • 3

    The duration of CHD for three years or more is associated with a higher likelihood of insomnia among patients.

  • 4

    Insomnia exacerbates cardiovascular issues by activating the sympathetic nervous system and increasing inflammatory responses.

  • 5

    Early identification and management of insomnia in CHD patients are crucial, particularly for those with modifiable risk factors.

Original Source(s)

Prevalence and influencing factors of insomnia in patients with coronary heart disease: a systematic review and meta-analysis

  • by Shu-lan Liu, Ya Chen, Xiao-di Bai, Ting Xu, He-yao Xu, Si-yu Lin, Xin-yao Zhou, Yun-lan Jiang

  • April 1, 2026

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study.

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.